SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 28th, 2017 • NuLife Sciences, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 12, 2017, by and between NuLife Sciences, Inc. , a Nevada corporation, with headquarters located at 2618 San Miguel, Suite 203, Newport Beach, California 92660 (the “Company”), and FIRSTFIRE GLOBAL OPPORTUNITIES FUND, LLC, a Delaware limited liability company, with its address at 1040 First Avenue, Suite 190, New York, NY 10022 (the “Buyer”).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • September 28th, 2017 • NuLife Sciences, Inc. • Pharmaceutical preparations • California
This Note Purchase Agreement (this “Agreement”) is made and entered into as of the 23rd day of August 2017, by and between NuLife Sciences Inc., a Nevada corporation (“Seller”) and Matthew Hayden (“Purchaser”), collectively referred to herein as the “Parties” or individually as a “Party”.
SETTLEMENT, GENERAL RELEASE AND CONVERSION AGREEMENTGeneral Release and Conversion Agreement • September 28th, 2017 • NuLife Sciences, Inc. • Pharmaceutical preparations • Nevada
THIS SETTLEMENT, GENERAL RELEASE AND CONVERSION AGREEMENT (the “Agreement”) is made and entered into on July 20, 2017, by and among Sean Clarke, a resident of the state of California, County of Orange (“Clarke ”) and NuLife Sciences Inc., a Nevada corporation (the “Company”). The Company and Clarke are collectively referred to as the “Parties”.
